GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) » Definitions » Cyclically Adjusted PB Ratio

Nanjing King-Friend Biochemical Pharmaceutical Co (SHSE:603707) Cyclically Adjusted PB Ratio : 4.41 (As of Jun. 04, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Nanjing King-Friend Biochemical Pharmaceutical Co Cyclically Adjusted PB Ratio?

As of today (2025-06-04), Nanjing King-Friend Biochemical Pharmaceutical Co's current share price is ¥11.11. Nanjing King-Friend Biochemical Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ¥2.52. Nanjing King-Friend Biochemical Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is 4.41.

The historical rank and industry rank for Nanjing King-Friend Biochemical Pharmaceutical Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

SHSE:603707' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 4.03   Med: 4.39   Max: 5.44
Current: 4.47

During the past years, Nanjing King-Friend Biochemical Pharmaceutical Co's highest Cyclically Adjusted PB Ratio was 5.44. The lowest was 4.03. And the median was 4.39.

SHSE:603707's Cyclically Adjusted PB Ratio is ranked worse than
77.87% of 696 companies
in the Drug Manufacturers industry
Industry Median: 1.975 vs SHSE:603707: 4.47

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Nanjing King-Friend Biochemical Pharmaceutical Co's adjusted book value per share data for the three months ended in Mar. 2025 was ¥4.071. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥2.52 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Nanjing King-Friend Biochemical Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Nanjing King-Friend Biochemical Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing King-Friend Biochemical Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Nanjing King-Friend Biochemical Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Nanjing King-Friend Biochemical Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 5.60

Competitive Comparison of Nanjing King-Friend Biochemical Pharmaceutical Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Nanjing King-Friend Biochemical Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanjing King-Friend Biochemical Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nanjing King-Friend Biochemical Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Nanjing King-Friend Biochemical Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


;
;

Nanjing King-Friend Biochemical Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Nanjing King-Friend Biochemical Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=11.11/2.52
=4.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanjing King-Friend Biochemical Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Nanjing King-Friend Biochemical Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=4.071/115.1156*115.1156
=4.071

Current CPI (Mar. 2025) = 115.1156.

Nanjing King-Friend Biochemical Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201312 0.779 97.624 0.919
201412 0.772 99.000 0.898
201512 0.817 100.600 0.935
201603 0.000 102.200 0.000
201606 0.000 101.400 0.000
201609 0.000 102.400 0.000
201612 0.984 102.600 1.104
201703 1.025 103.200 1.143
201706 1.076 103.100 1.201
201709 1.248 104.100 1.380
201712 1.305 104.500 1.438
201803 1.342 105.300 1.467
201806 1.403 104.900 1.540
201809 1.472 106.600 1.590
201812 1.535 106.500 1.659
201903 1.628 107.700 1.740
201906 1.671 107.700 1.786
201909 1.776 109.800 1.862
201912 1.879 111.200 1.945
202003 2.012 112.300 2.062
202006 2.044 110.400 2.131
202009 2.171 111.700 2.237
202012 2.358 111.500 2.434
202103 2.534 112.662 2.589
202106 2.625 111.769 2.704
202109 2.812 112.215 2.885
202112 3.327 113.108 3.386
202203 3.526 114.335 3.550
202206 3.605 114.558 3.623
202209 3.720 115.339 3.713
202212 3.816 115.116 3.816
202303 4.022 115.116 4.022
202306 4.092 114.558 4.112
202309 4.225 115.339 4.217
202312 3.589 114.781 3.599
202403 3.700 115.227 3.696
202406 3.757 114.781 3.768
202409 3.881 115.785 3.859
202412 4.018 114.893 4.026
202503 4.071 115.116 4.071

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Nanjing King-Friend Biochemical Pharmaceutical Co  (SHSE:603707) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Nanjing King-Friend Biochemical Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Nanjing King-Friend Biochemical Pharmaceutical Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanjing King-Friend Biochemical Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
1/16 Xuefu Road, Nanjing High-Tech Zone, Nanjing, CHN, 210061
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd is a China-based company engaged in the research and development, import and export of medicines and health products. The main products of the company are Heparin sodium and low molecular weight heparin. Geographically, the business activities are carried out through China and it exports the product mainly to the European and American countries.
Executives
Huang Xi Wei Director
Liu Zu Qing Supervisors
Xie Ju Hua Director
Wu Gui Ping senior management
Tang Yong Qun Director
Qian Xiao Jie senior management

Nanjing King-Friend Biochemical Pharmaceutical Co Headlines

No Headlines